SPRYD7 and colorectal carcinoma: The opposite trend would be associated with the different metastatic properties of the cells and the different protein levels of SPRYD7, which induced higher in vitro and in vivo effects on the poorly metastatic KM12C cells than on highly metastatic-to-liver KM12SM CRC cells.